Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...
Ocaliva, a farnesoid X receptor agonist, was withdrawn from the U.S. market due to FDA concerns about liver injury in patients. Initially approved in 2016 under an accelerated pathway, Ocaliva faced ...
France and Spain received more asylum applications in the first half of 2025 than Germany, with more Venezuelan and fewer Syrian applications partly responsible. Germany is no longer the country where ...
Join our community of jazz lovers. Alyn Shipton is waiting for your requests: email jazzrecordrequests@bbc.co.uk or use #jazzrecordrequests on social. Show more Alyn Shipton presents a selection of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback